210 related articles for article (PubMed ID: 27190045)
1. Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women.
Yang HP; Murphy KR; Pfeiffer RM; George N; Garcia-Closas M; Lissowska J; Brinton LA; Wentzensen N
Am J Epidemiol; 2016 May; 183(9):800-14. PubMed ID: 27190045
[TBL] [Abstract][Full Text] [Related]
2. Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States).
Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Vine MF; Berchuck A
Cancer Causes Control; 2002 Nov; 13(9):807-11. PubMed ID: 12462545
[TBL] [Abstract][Full Text] [Related]
3. The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3).
Trabert B; Tworoger SS; O'Brien KM; Townsend MK; Fortner RT; Iversen ES; Hartge P; White E; Amiano P; Arslan AA; Bernstein L; Brinton LA; Buring JE; Dossus L; Fraser GE; Gaudet MM; Giles GG; Gram IT; Harris HR; Bolton JH; Idahl A; Jones ME; Kaaks R; Kirsh VA; Knutsen SF; Kvaskoff M; Lacey JV; Lee IM; Milne RL; Onland-Moret NC; Overvad K; Patel AV; Peters U; Poynter JN; Riboli E; Robien K; Rohan TE; Sandler DP; Schairer C; Schouten LJ; Setiawan VW; Swerdlow AJ; Travis RC; Trichopoulou A; van den Brandt PA; Visvanathan K; Wilkens LR; Wolk A; Zeleniuch-Jacquotte A; Wentzensen N;
Cancer Res; 2020 Mar; 80(5):1210-1218. PubMed ID: 31932455
[TBL] [Abstract][Full Text] [Related]
4. Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies.
Pelucchi C; Galeone C; Talamini R; Bosetti C; Montella M; Negri E; Franceschi S; La Vecchia C
Am J Obstet Gynecol; 2007 Jan; 196(1):83.e1-7. PubMed ID: 17240246
[TBL] [Abstract][Full Text] [Related]
5. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
[TBL] [Abstract][Full Text] [Related]
6. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.
Schildkraut JM; Bastos E; Berchuck A
J Natl Cancer Inst; 1997 Jul; 89(13):932-8. PubMed ID: 9214672
[TBL] [Abstract][Full Text] [Related]
7. Lifetime number of ovulatory cycles and epithelial ovarian cancer risk in African American women.
Peres LC; Moorman PG; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Funkhouser E; Peters ES; Schwartz AG; Terry PD; Abbott SE; Camacho F; Wang F; Schildkraut JM
Cancer Causes Control; 2017 May; 28(5):405-414. PubMed ID: 28251458
[TBL] [Abstract][Full Text] [Related]
8. Influence of reproductive factors on mortality after epithelial ovarian cancer diagnosis.
Robbins CL; Whiteman MK; Hillis SD; Curtis KM; McDonald JA; Wingo PA; Kulkarni A; Marchbanks PA
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2035-41. PubMed ID: 19589914
[TBL] [Abstract][Full Text] [Related]
9. Ovulation and risk of epithelial ovarian cancer.
Purdie DM; Bain CJ; Siskind V; Webb PM; Green AC
Int J Cancer; 2003 Mar; 104(2):228-32. PubMed ID: 12569579
[TBL] [Abstract][Full Text] [Related]
10. Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup.
Schildkraut JM; Moorman PG; Bland AE; Halabi S; Calingaert B; Whitaker R; Lee PS; Elkins-Williams T; Bentley RC; Marks JR; Berchuck A
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):585-93. PubMed ID: 18349276
[TBL] [Abstract][Full Text] [Related]
11. Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.
Terry KL; Titus-Ernstoff L; McKolanis JR; Welch WR; Finn OJ; Cramer DW
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):30-5. PubMed ID: 17220329
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for epithelial ovarian tumours of borderline malignancy.
Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology of endometrial and ovarian cancer.
Cramer DW
Hematol Oncol Clin North Am; 2012 Feb; 26(1):1-12. PubMed ID: 22244658
[TBL] [Abstract][Full Text] [Related]
14. Duration of ovarian hormone exposure and gynecological cancer risk in Korean women: the Korean Heart Study.
Jung KJ; Park C; Yun YD; Jee SH
Cancer Epidemiol; 2016 Apr; 41():1-7. PubMed ID: 26773407
[TBL] [Abstract][Full Text] [Related]
15. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study.
Tung KH; Goodman MT; Wu AH; McDuffie K; Wilkens LR; Kolonel LN; Nomura AM; Terada KY; Carney ME; Sobin LH
Am J Epidemiol; 2003 Oct; 158(7):629-38. PubMed ID: 14507598
[TBL] [Abstract][Full Text] [Related]
16. Lifetime ovulations and epithelial ovarian cancer risk and survival: A systematic review and meta-analysis.
Fu Z; Taylor S; Modugno F
Gynecol Oncol; 2022 Jun; 165(3):650-663. PubMed ID: 35473671
[TBL] [Abstract][Full Text] [Related]
17. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis.
Tung KH; Wilkens LR; Wu AH; McDuffie K; Nomura AM; Kolonel LN; Terada KY; Goodman MT
Am J Epidemiol; 2005 Feb; 161(4):321-9. PubMed ID: 15692075
[TBL] [Abstract][Full Text] [Related]
18. Dietary cadmium intake and risk of breast, endometrial and ovarian cancer in Danish postmenopausal women: a prospective cohort study.
Eriksen KT; Halkjær J; Sørensen M; Meliker JR; McElroy JA; Tjønneland A; Raaschou-Nielsen O
PLoS One; 2014; 9(6):e100815. PubMed ID: 24963789
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Kotsopoulos J; Lubinski J; Gronwald J; Cybulski C; Demsky R; Neuhausen SL; Kim-Sing C; Tung N; Friedman S; Senter L; Weitzel J; Karlan B; Moller P; Sun P; Narod SA;
Int J Cancer; 2015 Sep; 137(5):1136-46. PubMed ID: 25482078
[TBL] [Abstract][Full Text] [Related]
20. Association of Endogenous Pregnenolone, Progesterone, and Related Metabolites with Risk of Endometrial and Ovarian Cancers in Postmenopausal Women: The B
Trabert B; Geczik AM; Bauer DC; Buist DSM; Cauley JA; Falk RT; Gierach GL; Hue TF; Lacey JV; LaCroix AZ; Michels KA; Tice JA; Xu X; Brinton LA; Dallal CM
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2030-2037. PubMed ID: 34465588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
